ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,321.41
0.25%
US Tech 100
18,232.80
0.20%
다우존스 지수
39,872.99
0.17%
Bitcoin
69,548.27
-2.66%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. DMK Pharmaceuticals Corporation (DMK)

  7. DMK Pharmaceuticals Corporation (DMK) 뉴스

DMK DMK Pharmaceuticals Corporation

0.232
0.00 (0.00%)
최종 업데이트: 09:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
DMK Pharmaceuticals Corporation DMK 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% 0.232 09:00:00
개장가 저가 고가 종가 전일 종가
0.232
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
22/03/202403:23EDGAR2Form 25-NSE - Notification filed by national security..
08/02/202407:19EDGAR2Form 8-K - Current report
07/02/202400:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/02/202423:00EDGAR2Form 8-K - Current report
01/02/202407:17EDGAR2Form 8-K - Current report
24/01/202407:23EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
24/01/202407:22EDGAR2Form 8-K - Current report
04/01/202407:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/01/202407:02EDGAR2Form 8-K - Current report
04/01/202407:00EDGAR2Form 8-K - Current report
22/12/202302:31EDGAR2Form 8-K - Current report
21/12/202322:15GLOBEDMK Pharmaceuticals Regains Full Rights to Commercialize..
05/12/202306:47EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/12/202306:45EDGAR2Form 8-K - Current report
29/11/202306:41EDGAR2Form 8-K - Current report
28/11/202322:05GLOBEDMK Pharmaceuticals Regains Full Rights from US WorldMeds..
16/11/202306:39EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
16/11/202306:20EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
16/11/202306:11EDGAR2Form 8-K - Current report
16/11/202306:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/11/202305:57EDGAR2Form 8-K - Current report
14/11/202321:30GLOBEDMK Pharmaceuticals Reports Third Quarter 2023 Financial..
14/11/202300:52GLOBEDMK Pharmaceuticals Announces Presentation of Preclinical..
03/11/202305:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202305:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/10/202320:30GLOBEDMK Pharmaceuticals Announces Inducement Option Grant Under..
26/10/202306:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202306:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
21/10/202305:15GLOBEDMK Pharmaceuticals Announces Inducement Option Grant Under..
20/10/202306:07EDGAR2Form 8-K - Current report
20/10/202305:05GLOBEDMK Pharmaceuticals Restructures Executive Team to Support..
18/10/202305:37EDGAR2Form 8-K - Current report
18/10/202301:28EDGAR2Form PX14A6G - Notice of exempt solicitation submitted by..
13/10/202305:22EDGAR2Form DEFC14A - Definitive proxy statement, contested..
10/10/202319:01EDGAR2Form 8-K - Current report
03/10/202305:49EDGAR2Form PREC14A - Preliminary proxy statements, contested..
26/09/202321:37EDGAR2Form SC 13D/A - General statement of acquisition of..
20/09/202306:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/09/202301:00GLOBEAdamis Pharmaceuticals Changes Name to DMK Pharmaceuticals..

최근 히스토리

NASDAQ
DMK
DMK Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유